- Supported exchanges /
- NSE /
- GLS.NSE
Glenmark Life Sciences Limited (GLS NSE) stock market data APIs
Glenmark Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Nirma Limited.
Glenmark Life Sciences Limited Financial Data Overview
| 1092.65 | |
| 1040.05 | |
| - | |
| 1110 | |
| 1034 | |
| 624.6-1335.1 | |
| 128 525 M | |
| 30.2999 | |
| 123 M | |
| 22 049 M | |
| 7.75 | |
| 0.16 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Glenmark Life Sciences Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 22 049 M
- EBITDA 6 027 M
- Earnings Per Share 34.51
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Glenmark Life Sciences Limited Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast 10
Get Glenmark Life Sciences Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
